|
SOS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.030290E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.615400E-04 |
| Normal-vs-Stage2 |
9.632300E-02 |
| Normal-vs-Stage3 |
3.400600E-01 |
| Normal-vs-Stage4 |
5.090400E-01 |
| Stage1-vs-Stage2 |
8.605600E-01 |
| Stage1-vs-Stage3 |
2.254400E-02 |
| Stage1-vs-Stage4 |
3.89060000000052E-05 |
| Stage2-vs-Stage3 |
2.718200E-01 |
| Stage2-vs-Stage4 |
4.415800E-02 |
| Stage3-vs-Stage4 |
1.191370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.619000E-03 |
| Normal-vs-AfricanAmerican |
7.472400E-01 |
| Normal-vs-Asian |
4.698800E-03 |
| Caucasian-vs-AfricanAmerican |
3.935600E-02 |
| Caucasian-vs-Asian |
1.964600E-01 |
| AfricanAmerican-vs-Asian |
2.662400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.522300E-02 |
| Normal-vs-Female |
5.317000E-03 |
| Male-vs-Female |
2.181200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.881800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.144600E-03 |
| Normal-vs-Age(61-80Yrs) |
7.831700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.182400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.258000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.183400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.721400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.178100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.343560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.970200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.578690E-04 |
| Normal-vs-Grade 2 |
1.371190E-04 |
| Normal-vs-Grade 3 |
3.207000E-01 |
| Normal-vs-Grade 4 |
3.936200E-01 |
| Grade 1-vs-Grade 2 |
2.782000E-01 |
| Grade 1-vs-Grade 3 |
1.681640E-03 |
| Grade 1-vs-Grade 4 |
1.585650E-04 |
| Grade 2-vs-Grade 3 |
8.164900E-04 |
| Grade 2-vs-Grade 4 |
1.63798999999187E-05 |
| Grade 3-vs-Grade 4 |
5.334200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.51189999987001E-07 |
| Normal-vs-ccB subtype |
2.715600E-01 |
| ccA subtype-vs-ccB subtype |
8.34660000000875E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.744500E-03 |
| Normal-vs-N1 |
7.679000E-01 |
| N0-vs-N1 |
2.218000E-01 |
|
|
